These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 8213473)
1. Use of calcium channel antagonists for cardiovascular disease. Yedinak KC Am Pharm; 1993 Aug; NS33(8):49-64; quiz 64-6. PubMed ID: 8213473 [TBL] [Abstract][Full Text] [Related]
2. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. Opie LH Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329 [TBL] [Abstract][Full Text] [Related]
3. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension. Walton T; Symes LR Clin Pharm; 1993 Apr; 12(4):261-75. PubMed ID: 8458178 [TBL] [Abstract][Full Text] [Related]
5. Similarities and differences between calcium antagonists: pharmacological aspects. van Zwieten PA; Pfaffendorf M J Hypertens Suppl; 1993 Mar; 11(1):S3-11. PubMed ID: 8483019 [TBL] [Abstract][Full Text] [Related]
6. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists]. Rameis H Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031 [TBL] [Abstract][Full Text] [Related]
7. Calcium channel antagonists. What do the second-generation agents have to offer? Salerno SM; Zugibe FT Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298 [TBL] [Abstract][Full Text] [Related]
8. Calcium-channel blockers and the elderly. Ryan C Compr Ther; 1990 Jun; 16(6):51-4. PubMed ID: 2373003 [TBL] [Abstract][Full Text] [Related]
9. The role of calcium antagonists in the treatment of myocardial ischemia. Follath F Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists. Apostolakos MJ; Varon ME New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275 [TBL] [Abstract][Full Text] [Related]
11. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine. Little WC; Cheng CP; Elvelin L; Nordlander M Cardiovasc Drugs Ther; 1995 Oct; 9(5):657-63. PubMed ID: 8573548 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists. Vetrovec GW Am J Cardiol; 1994 Jan; 73(3):34A-38A. PubMed ID: 8310974 [TBL] [Abstract][Full Text] [Related]
13. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction. Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944 [TBL] [Abstract][Full Text] [Related]
14. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. Opie LH Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677 [TBL] [Abstract][Full Text] [Related]
15. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs. Opie LH Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199 [TBL] [Abstract][Full Text] [Related]